Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma
Clinical trial NCT05693012 · UNKNOWN
Trial details
- NCT number
- NCT05693012
- Sponsor
- Qiu Lugui
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-01
- Primary completion
- 2023-12-31
- Enrollment
- 398
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.